Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Imfinzi approved in China for extensive-stage SCLC

19 July 2021 07:00 BST Imfinzi approved in China for the treatmentof extensive-stage small cell lung cancer Only PD-1/PD-L1 immunotherapy to demonstrate both a significant survival benefit and improved response rate in combination with a choice of chemotherapies AstraZeneca’s Imfinzi (durvalumab) has been approved in China for the 1st-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC), in combination with standard of care platinum chemotherapy (etoposide plus a choice of either carboplatin or cisplatin). The approval by China’s National

Peab rebuilds prison in Härnosand

Peab has been commissioned to rebuild and renovate the former prison in Härnösand. The customer is Intea Fastigheter and the contract is worth SEK 157 million.The Swedish Prison and Probation Service plans to reopen the prison in Härnösand. Intea Fastigheter owns the building and has awarded Peab the contract to refit the premises to meet current security class 2 standards and prepare space for the national transportation unit (NTE). The project includes rebuilding and renovating the facility - parts of which date back to the 1800s - to suit the incoming operations as well as maintenance

CELLINK launches the S.NEST, a high-throughput microbioreactor with real-time monitoring to ensure maximum cell growth and streamlined workflows

CYTENA Bioprocess Solutions, a CELLINK company, has launched the S.NEST™, a state-of-the art microbioreactor that maximizes cell growth while monitoring and analyzing cell conditions from start to finish. Well-known for combining innovative bioscience technologies with best-in-class software development, CYTENA Bioprocess Solutions has developed their new microbioreactor to disrupt the field of cell line development (CLD). Microbioreactors have been instrumental in a string of research breakthroughs in CLD for a range of downstream applications, but with the addition of real-time

GomSpace (provider of nanosatellites) announces its quarterly results for the second quarter 2021

Stockholm, July 19, 2021. GomSpace Group AB (the “Company”) announces its interim report for the second quarter of 2021. The report is available on the Company’s homepage (www.gomspace.com). The following is taken from the quarterly report: Second quarter summary 1 April – 30 June 2021 (2020) · Order intake increased to T.SEK 199,459 (42,342) · Net revenues increased to T.SEK 47,535 (42,729) · Gross margin increased to 14% (11%) · Operating profit (loss) improved to a negative T.SEK 12,331 (a negative 14,859) · Earnings per share were a negative SEK 0.22 (a negative 0.

Quarterly Report Q2 2021

Significant sales growth and margin recoverySecond quarter · Net sales increased by 19% to SEK 23,648 M (19,953), with strong organic growth of 23% (–18) and acquired net growth of 5% (3). Currency effects amounted to –9% (0) · Very strong organic sales growth was reported by EMEIA, Americas, Entrance Systems and Global Technologies. The organic sales growth forAsia Pacific was stable · Four acquisitions with combined annual sales of about SEK 400 M were signed · Operating income (EBIT)[ ]increased by 71% and amounted to SEK 3,589 M (2,097), corresponding to an operating

Glycorex Transplantation AB (GTAB B): Universal Whole Blood: Presentation of results at two U.S. blood conferences

As previously announced, a leading center in the U.S. has tested our UBP-product for the manufacturing of universal whole blood. We can now announce that the results will be presented as poster presentations at the Society for the Advancement of Blood Management (SABM) and the AABB. In connection with these, abstracts will also be published in two different medical journals: "Anesthesia and Analgesia" and "Transfusion".Massive bleeding is one of the leading causes of death in severe trauma. Evidence is growing suggesting that transfusion of whole blood is most appropriate in these cases,

Elgood Development Well 48/22c-7 Flow Test Results

19 July 2021 IOG plc Successful Elgood Development Well 48/22c-7 Flow Test Results IOG plc (“IOG”, or “the Company”), (AIM: IOG.L), the UK gas company targeting growth and high returns via an infrastructure-led hub strategy, is pleased to provide an update on the Elgood well 48/22c-7, our first Phase 1 development well. The well was drilled horizontally through the reservoir section to a Total Depth of 15,472ft Measured Depth (MD), intersecting 1,080 ft of high-quality Permian Leman Sandstone reservoir along hole between 14,290 ft MD and 15,370 ft MD, with a net:gross ratio of

Coor acquires Veolia Technical Management

Coor today signed an agreement relating to the acquisition of the assets in the business area Veolia Technical Management, part of Veolia Sverige AB, which is divesting its operations in Sweden and Norway. The business area has some 250 employees and annual sales of some SEK 500 M. The acquisition further strengthens Coor’s offering and competencies in technical property services and maintenance.The purchase consideration totals SEK 180 M. The acquisition is financed within the framework of Coor’s existing financing in its entirety. The transaction takes the form of an asset transfer mainly

Nyfosa Finland aqcuires properties in Finland at a value of SEK 149 million

2021-07-19Nyfosa Finland has acquired a portfolio with industrial and retail properties in the Finnish regional cities of Oulu and Hyvinkää. The acquisition amounts to a total value of EUR 14.7 million, corresponding to approximately SEK 149 million.The five modern properties have a total area of approximately 9,000 square meters with an annual rental value of EUR 1.1 million, corresponding to approximately SEK 11.6 million. The portfolio is located in the regional cities of Oulu and Hyvinkää with two established tenants, Suomen Autokauppa Oy (SAKA) och Suomen Autohuolto Oy (SAH), focused

Nyfosa aqcuires property portfolio in Finland at a value of MSEK 149

Nyfosa has acquired a portfolio with industrial and retail properties in the Finnish regional cities of Oulu and Hyvinkää. The acquisition amounts to a total value of MEUR 14.7, corresponding to approximately MSEK 149.The five modern properties have a total area of approximately 9 thousand square meters with an annual rental value of MEUR 1.1, corresponding to approximately MSEK 11.6. The portfolio is located in the regional cities of Oulu and Hyvinkää with two established tenants, Soumen Autokauppa Oy (SAKA) och Soumen Autohoulto Oy (SAH), focused on car sales business and services. The

Skanska builds highway section in Czech Republic for EUR 77M, about SEK 780M

Skanska has signed a contract with National Highway Authority of the Czech Republic to build a highway section in Staré Město, eastern Czech Republic. The contract is worth EUR 77M, about SEK 780M, which will be included in the order bookings for Europe for the third quarter 2021.The construction of the 8.8-kilometer section between Staré Město – Moravský Písek, including nine bridges and two multi-level crossings, will be financed by the European Regional Development Fund, OP Integrated Infrastructure 2014-2020 and the state budget. The expected construction commencement date is August

Last day of trading and delisting of Aros Bostad's preference shares of class A

Today, 19 July 2021, is the last day of trading in Aros Bostadsutveckling AB's (publ) ("Aros Bostad" or the "Company") preference shares of class A, which today are also delisted from Nasdaq First North Growth Market.As the Company has previously communicated, the board of directors of the Company has resolved to redeem all 104,041 preference shares of class A. The redemption amount per share is, as stipulated in the articles of association, SEK 100, SEK 10,404,100 in total for all shares. Payment to holders of preference shares of class A on the record date 21 July 2021 is expected to

Interim Report 1 for the period 1 January - 30 June 2021

INCREASED FOCUS ON MARITIME AND ON ENSURED PROFITABILITY During the quarter, Climeon carried out commissioning for customers within both maritime and geothermal energy. Six modules were commissioned on Virgin Voyages' ship Valiant Lady and four Heat Power modules at the Flúðir power plant. Climeon's Icelandic customer Varmaorka has laid out a new plan for expansion of geothermal power plants, with a significantly lower roll-out rate for the coming years. As a consequence of this, Climeon has decided, after the end of the quarter, to reduce the order backlog by SEK 467.5 million to SEK 180.

Filo Mining Reports 1,378m at 0.71% CuEq; including 676m at 0.92% CuEq at Filo del Sol

Vancouver, BC, July 19, 2021 /CNW/ - Filo Mining Corp. (TSXV: FIL) (Nasdaq First North Growth Market: FIL) (OTCQX: FLMMF) (“Filo Mining”, or the “Company”) is pleased to announce additional drill results from the Filo del Sol project in San Juan province, Argentina.  Highlights are listed below, along with accompanying figures: · Drillhole FSDH046 has returned the longest mineralized intersection on the project to date, was collared 200m to the east of FSDH032, and demonstrates strong mineralization to over 1,400m below surface. · FSDH046 returned 676m at 0.92% CuEq (0.57% Cu; 0.34g/

Fatty liver more common in children of mothers with obesity

Children and young people whose mothers had a BMI greater than 30 during early pregnancy are at an increased risk of fatty liver disease. This is shown in a register-based study from Karolinska Institutet and Harvard University published in the journal Journal of Hepatology. As obesity rates increase also in women at a child-bearing age, more and more young people are at risk of developing fatty liver disease, the researchers say.“The findings are important because obesity is becoming more common at a young age, and fatty liver due to being overweight, is increasing in the world. If a

Stabilisation notice, end of stabilisation period and exercise of over-allotment option

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, FULLY OR PARTLY, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, CANADA, JAPAN, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE IN ACCORDANCE WITH APPLICABLE LAW.   DNB Markets, a part of DNB Bank ASA, Sweden Branch ("DNB"), acting in its capacity as stabilisation manager, notifies that stabilisation measures have been undertaken in the Aros Bostadsutveckling AB (publ) ("

Norway Royal Salmon ASA (NRS): Mandatory notification of trade

NTS ASA ("NTS") has on 16 July 2021 purchased through the market 417,311 shares in Norway Royal Salmon ASA ("NRS")at an average price of NOK 208.4176 per share. No shares were purchased at a price higher than the offer price in the mandatory offer. Following completion of these transactions, NTS controls directly and indirectly through Midt-norsk Havbruk AS 13.858.040 shares in NRS, equal to 31.80% of total number of issued and outstanding shares in NRS. Held together with the 1,624,607 shares that NTS shall acquire from Gåsø Næringsutvikling AS, NTS will control 15,482,647 shares in NRS,

Norway Royal Salmon ASA (NRS): Mandatory offer from NTS ASA

Reference is made to the stock exchange announcement published by NTS ASA today where NTS announced to launch a mandatory offer on all outstanding shares in Norway Royal Salmon ASA (“NRS”). A statement on the offer in accordance with section 6-16 of the Securities Trading Act will be published by or on behalf of the company at the latest one week prior to the end of the offer period. For further information please contact: Ola Loe, CFO, +47 911 79 411. This notification has been submitted pursuant to the Securities Trading Act § 5-12. The notification is submitted on behalf of

Norway Royal Salmon ASA (NRS): Mandatory notification of trade

Gåsø Næringsutvikling AS ("Gåsø Næringsutvikling") has today agreed to sell all of its 1,624,607 shares in Norway Royal Salmon ASA ("NRS") to NTS ASA("NTS"), corresponding to 3.72% of the total number of outstanding shares and votes in NRS. The transaction will be completed in accordance with the offer price in the mandatory offer, and settlement will be made prior to the expiration of the offer period in the mandatory offer. Following completion of this transaction, Gåsø Næringsutvikling will no longer hold Shares in NRS. Gåsø Næringsutvikling is considered a company that is a close

Norway Royal Salmon ASA (NRS): Mandatory notification of trade

In connection with a mandatory offer made by NTS ASA ("NTS") in accordance with chapter 6 of the Securities Trading Act, Gåsø Næringsutvikling AS ("Gåsø Næringsutvikling") has agreed to sell all of its 1,624,607 shares in Norway Royal Salmon ASA ("NRS") to NTS, corresponding to 3.72% of the total number of outstanding shares and votes in NRS. The transaction will be completed in accordance with the offer price in the mandatory offer, and settlement will be made prior to the expiration of the offer period in the mandatory offer. Following completion of this transaction, Gåsø Næringsutvikling

Exercise of the over-allotment option in the IPO of RevolutionRace

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. OTHER RESTRICTIONS ARE APPLICABLE, PLEASE SEE “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE.ABG Sundal Collier AB (”ABGSC”) and Carnegie Investment Bank AB (publ) ("Carnegie") have today notified RVRC Holding AB (publ) ("RevolutionRace" or the ”Company”) and

ShaMaran Announces Successful Placement of New USD 300 Million Bond

Vancouver, BC, July 16, 2021 /CNW/ - ShaMaran Petroleum Corp. ("ShaMaran" or the "Company") (TSX VENTURE: SNM) (NASDAQ First North: SNM) is pleased to announce that a new USD 300 million bond, with 4-year tenor has been priced at 12% fixed semi-annual coupon. The new bond is issued at 98.5% of nominal value which is applicable to both new money under the Initial Issue Amount of USD 111.5 million and the refinancing of existing debt under the Tap Issue. Settlement of the Initial Issue Amount is expected to be on July 30, 2021.  The proceeds from the bond issue will be used to refinance USD

Aquaporin receives significant order from Turkish customer

(Kgs. Lyngby, Denmark, 16 July 2021) Aquaporin, a water technology company aiming to contribute to a more sustainable world by focusing on encouraging responsible consumption of water, has secured an order for 2,500 ZERO water purifiers. This large order of Point-of-Use drinking water purification systems marks the beginning of a new commercial relationship with a large Turkish conglomerate with an extensive electronics and appliances manufacturing and distribution network. Matt Boczkowski, Aquaporin CCO and Deputy CEO says: “We’re honored to enter into a commercial collaboration with

There are no items matching the current filter
There are no more items matching the current filter
Back to top